Jeffrey William Henderson - Net Worth and Insider Trading
Jeffrey William Henderson Net Worth
The estimated net worth of Jeffrey William Henderson is at least $14 Million dollars as of 2025-05-30. Jeffrey William Henderson is the CFO of Cardinal Health Inc and owns about 67,190 shares of Cardinal Health Inc (CAH) stock worth over $10 Million. Jeffrey William Henderson is the Director of Halozyme Therapeutics Inc and owns about 28,611 shares of Halozyme Therapeutics Inc (HALO) stock worth over $2 Million. Jeffrey William Henderson is also the Director of Becton Dickinson & Co and owns about 8,030 shares of Becton Dickinson & Co (BDX) stock worth over $1 Million. Besides these, Jeffrey William Henderson also holds Qualcomm Inc (QCOM) , FibroGen Inc (FGEN) . Details can be seen in Jeffrey William Henderson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey William Henderson has not made any transactions after 2025-04-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Jeffrey William Henderson
Jeffrey William Henderson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey William Henderson owns 5 companies in total, including FibroGen Inc (FGEN) , Halozyme Therapeutics Inc (HALO) , and Qualcomm Inc (QCOM) among others .
Click here to see the complete history of Jeffrey William Henderson’s form 4 insider trades.
Insider Ownership Summary of Jeffrey William Henderson
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
FGEN | FibroGen Inc | 2023-09-01 | director |
HALO | Halozyme Therapeutics Inc | 2025-04-28 | director |
QCOM | Qualcomm Inc | 2023-02-23 | director |
![]() | ![]() | 2025-02-10 | director |
![]() | ![]() | 2014-08-27 | Executive Vice President |
Jeffrey William Henderson Latest Holdings Summary
Jeffrey William Henderson currently owns a total of 5 stocks. Among these stocks, Jeffrey William Henderson owns 67,190 shares of Cardinal Health Inc (CAH) as of August 27, 2014, with a value of $10 Million and a weighting of 75.91%. Jeffrey William Henderson owns 28,611 shares of Halozyme Therapeutics Inc (HALO) as of April 28, 2025, with a value of $2 Million and a weighting of 11.49%. Jeffrey William Henderson also owns 8,030 shares of Becton Dickinson & Co (BDX) as of February 10, 2025, with a value of $1 Million and a weighting of 10.24%. The other 2 stocks Qualcomm Inc (QCOM) , FibroGen Inc (FGEN) have a combined weighting of 2.36% among all his current holdings.
Latest Holdings of Jeffrey William Henderson
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CAH | Cardinal Health Inc | 2014-08-27 | 67,190 | 153.99 | 10,346,588 |
HALO | Halozyme Therapeutics Inc | 2025-04-28 | 28,611 | 54.73 | 1,565,880 |
BDX | Becton Dickinson & Co | 2025-02-10 | 8,030 | 173.82 | 1,395,775 |
QCOM | Qualcomm Inc | 2023-02-23 | 2,105 | 148.34 | 312,256 |
FGEN | FibroGen Inc | 2023-09-01 | 28,866 | 0.32 | 9,182 |
Holding Weightings of Jeffrey William Henderson
Jeffrey William Henderson Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey William Henderson has made a total of 0 transactions in Cardinal Health Inc (CAH) over the past 5 years. The most-recent trade in Cardinal Health Inc is the sale of 26,567 shares on August 27, 2014, which brought Jeffrey William Henderson around $2 Million.
According to the SEC Form 4 filings, Jeffrey William Henderson has made a total of 7 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Halozyme Therapeutics Inc is the sale of 4,497 shares on April 28, 2025, which brought Jeffrey William Henderson around $271,484.
According to the SEC Form 4 filings, Jeffrey William Henderson has made a total of 1 transactions in Becton Dickinson & Co (BDX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Becton Dickinson & Co is the acquisition of 1,500 shares on February 10, 2025, which cost Jeffrey William Henderson around $350,430.
More details on Jeffrey William Henderson's insider transactions can be found in the Insider Trading History of Jeffrey William Henderson table.Insider Trading History of Jeffrey William Henderson
- 1
Jeffrey William Henderson Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey William Henderson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey William Henderson is -27.15%. GuruFocus also compares Jeffrey William Henderson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey William Henderson within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey William Henderson's insider trading performs compared to the benchmark.
Performance of Jeffrey William Henderson
Jeffrey William Henderson Ownership Network
Ownership Network List of Jeffrey William Henderson
Ownership Network Relation of Jeffrey William Henderson

Jeffrey William Henderson Owned Company Details
What does FibroGen Inc do?
Who are the key executives at FibroGen Inc?
Jeffrey William Henderson is the director of FibroGen Inc. Other key executives at FibroGen Inc include Chief Commercial Officer Thane Wettig , director & Chief Executive Officer Enrique A Conterno , and SVP & China Operations Christine Chung .
FibroGen Inc (FGEN) Insider Trades Summary
Over the past 18 months, Jeffrey William Henderson made no insider transaction in FibroGen Inc (FGEN). Other recent insider transactions involving FibroGen Inc (FGEN) include a net purchase of 195,000 shares made by Thane Wettig , a net purchase of 300,000 shares made by James A Schoeneck , and a net purchase of 22,123 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of FibroGen Inc (FGEN) in total and bought 445,000 shares, with a net purchase of 445,000 shares. During the past 18 months, 0 shares of FibroGen Inc (FGEN) were sold and 517,123 shares were bought by its insiders, resulting in a net purchase of 517,123 shares.
FibroGen Inc (FGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
FibroGen Inc Insider Transactions
Jeffrey William Henderson Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey William Henderson. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jeffrey William Henderson's mailing address is: Dublin Oh 43017.